Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Developed by a multidisciplinary team of dietitians, public health nutritionists, and food technology experts, it offers an evidence-based roadmap for supporting GLP-1 therapy
Severe but rare side effects can include pancreatitis, medullary thyroid cancer, acute kidney injury, and worsening diabetes related retinopathy
The market is then expected to grow at a CAGR of 15.5% from 2030 and reach $286,412.5 million in 2035
These agonists not only enhance GLP-1 release but also suppress the expression of pro-inflammatory cytokines, including IL-2, IL-17a, interferon-, and TNF- (Yusta et al., 2015)
US$ 23.60
US$ 29.60
US$ 27.03
US$ 20.80
US$ 29.09
US$ 26.89
US$ 24.44
US$ 23.44
